Overview


According to FutureWise analysis the market for blood bags in 2023 is US$ 0.29 billion, and is expected to reach US$ 0.61 billion by 2031 at a CAGR of 9.60%.

Blood and its components, including platelets, plasma, and cryoprecipitate, are transferred, collected, stored, and transfused using a blood bag. It's usually made of biocompatible PVC and comes with collection tubes, needles, needle coverings, and clamps built in. Citrate Phosphate Dextrose Adenine (CPDA) blood bags, Saline Adenine Glucose Mannitol (SAGM) blood bags, and transfer bags are the most common types of blood bags on the market. They are divided into single, double, triple, and quadruple blood collection bags based on the sorts of transfusions they are used for. Surgical centres, trauma centres, emergency rooms, ambulatory care facilities, and critical care units all use these bags. Furthermore, the rising frequency of various blood-related medical conditions, such as anaemia, haemophilia, myeloma, and leukaemia, is pushing blood transfusion demand. The expansion of the blood bag market is being fueled by numerous invasive surgical operations in the sectors of cardiology, neurology, orthopaedics, oncology, and others. Blood banks, medical research laboratories, and diagnostic facilities are also being established as a result of increased investments in healthcare infrastructure development. The market for blood bags is also being boosted by the development of multiple blood donation programmes by various government entities and non-profit groups. The rising frequencies of fatal accidents, as well as the widespread presence of trauma centres around the world, are driving the worldwide blood bags market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Blood Bags Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Blood Bags Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Advacare Pharma
  • BL Life Sciences Private Limited
  • Demophorius Healthcare Ltd.
  • Fresenius SECo. KGaA.
  • Grifols S.A.
  • Haemonetics Corporation
  • HLL Lifecare Limited
  • Innvol
  • JMS Co. Ltd.
  • Kawasumi Laboratories, Inc.
  • Maco Pharma International GmbH
  • Mitra Industries Pvt. Ltd.
  • Neomedic Limited
  • Poly Medicure Ltd.
  • Span Healthcare Private Limited
  • Suru International Private Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • The Metrix Company Ltd.
  • Troge Medical GmbH.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Single Blood Bag
  • Double Blood Bag
  • Triple Blood Bag
  • Quadruple Blood Bag
  • Penta Blood Bag

By Application

  • Collection Blood Bag
  • Transfer Blood Bag

By Material

  • Poly Vinyl Chloride Blood Bag
  • Polyethylene Terephthalate Blood Bag
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centre
  • Blood Banks
  • Others

By Capacity

  • 100 ml Blood Bag
  • 150 ml Blood Bag
  • 250 ml Blood Bag
  • 300 ml Blood Bag
  • 350 ml Blood Bag
  • 400 ml Blood Bag
  • 450 ml Blood Bag
  • 500 ml Blood Bag

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Blood Bags Market By Product Type, By Application, By Material, By End User, By Capacity and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Blood Bags Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Blood Bags Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Blood Bags Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Blood Bags Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Single Blood Bag
        2. Double Blood Bag
        3. Triple Blood Bag
        4. Quadruple Blood Bag
        5. Penta Blood Bag

  • 8.   Blood Bags Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Collection Blood Bag
        2. Transfer Blood Bag

  • 9.   Blood Bags Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Poly Vinyl Chloride Blood Bag
        2. Polyethylene Terephthalate Blood Bag
        3. Others

  • 10.   Blood Bags Market, By End Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centre
        4. Blood Banks
        5. Others

  • 11.   Blood Bags Market, By Capacity Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 100 ml Blood Bag
        2. 150 ml Blood Bag
        3. 250 ml Blood Bag
        4. 300 ml Blood Bag
        5. 350 ml Blood Bag
        6. 400 ml Blood Bag
        7. 450 ml Blood Bag
        8. 500 ml Blood Bag

  • 12.   North America Blood Bags Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Blood Bags Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Blood Bags Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Blood Bags Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Blood Bags Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Advacare Pharma
            1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BL Life Sciences Private Limited
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Demophorius Healthcare Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Fresenius SECo. KGaA.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Grifols S.A.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Haemonetics Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. HLL Lifecare Limited
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Innvol
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. JMS Co. Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Kawasumi Laboratories, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Maco Pharma International GmbH
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Mitra Industries Pvt. Ltd.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Neomedic Limited
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Poly Medicure Ltd.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Span Healthcare Private Limited
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Suru International Private Ltd.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Teleflex Incorporated
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18.Terumo Corporation
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. The Metrix Company Ltd.
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Troge Medical GmbH.
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients